Competitive methane-reducing products released by end of 2024? | Binary | | | 7 months ago | |
Elanco stock rise by 10% post-Bovaer approval by 2024 end? | Binary | | | 7 months ago | |
Global endorsement and adoption rate of Bovaer by 2025 | Categorical | | | 7 months ago | |
Adoption level of Bovaer in US dairy industry by 2024 end | Categorical | | | 7 months ago | |
Impact of Bovaer on Elanco's market share by 2024 | Categorical | | | 7 months ago | |
Will Elanco's stock price increase by 10% or more by the end of 2024? | Binary | | | 3 months ago | |
Will Zenrelia™ achieve $50 million in sales in Q1 2025? | Binary | | | 3 months ago | |
What will be the total revenue generated by Zenrelia™ in its first year post-approval? | Categorical | | | 3 months ago | |
Will Zenrelia™ capture 20% of the veterinary dermatology market by mid-2025? | Binary | | | 3 months ago | |
Which competitor will Elanco outperform by the end of 2024 following Zenrelia™ approval? | Categorical | | | 3 months ago | |
Which region will have the highest sales of Zenrelia™ by mid-2025? | Categorical | | | 3 months ago | |
US dairy methane emissions significantly reduced by 2025 due to Bovaer? | Binary | | | 7 months ago | |
